Advertisement

Picture Berlin Partner Special Topic Well-trained Professionals 650x100px
Document › Details

DiaSorin S.p.A.. (11/9/17). "Press Release: Growth in Revenues and Net Profit in Q3 2017". Saluggia.

Organisations Organisation DiaSorin S.p.A. (FTSE Italia Mid Cap: DIA)
  Group DiaSorin (Group)
  Organisation 2 Siemens Healthcare GmbH (Siemens Healthineers)
  Group Siemens (Group)
Products Product ELISA assay (diagnostics) (enzyme linked immunosorbent assay)
  Product 2 Liaison XL analyzer
Index term Index term DiaSorin–Siemens: ELISA immunoassays, 201707– acquisition up to €47.5m of Siemens ELISA Dx portfolio/assets without employees + mftg capacity
Persons Person Fava, Riccardo (DiaSorin 201607 IR + Corporate Communications Director)
  Person 2 Di Terlizzi, Ines (DiaSorin 201607 Investor Relations)
     


   
Record changed: 2023-06-05

Advertisement

Picture EBD Group Biotech Showcase 2024 San Francisco 650x200px

More documents for DiaSorin (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Stier Group MIXiii Lifescience Healthtech Conference 650x300px




» top